J B Chemicals & Pharmaceuticals has allotted 43,450 equity shares under ESOS on 05 March 2024. Consequently, the issued, subscribed and paid up capital has increased from 15,51,51,350 equity shares of Re. 1 each to 15,51,94,800 equity shares of Re. 1 each.Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals has granted 76,000 time-based stock options and 114,000 performance-based options to an eligible employee of the Company under the Company`s Employees Stock Option Scheme �JBCPL Employee Stock Option Scheme 2021� (Scheme). The exercise price for these options is Rs. 1,022 per share.The total outstanding stock options stand at 52,10,886 (comprising of 21,56,920 time-based stock options and 30,53,966 performance-based stock options).Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals has granted 21,000 time-based stock options and 9,000 performance-based options to an eligible employee of the Company under the Company`s Employees Stock Option Scheme �JBCPL Employee Stock Option Scheme 2021� (�Scheme�). The exercise price for these options is Rs. 1,018 per share. The timebased options shall vest over one to three years.The total outstanding stock options stand at 50,20,886 (comprising of 20,80,920 time-based stock options and 29,39,966 performance-based stock options). Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 6 February 2024, inter alia, have recommended the interim dividend of Rs 5.5 per equity Share (i.e. 550%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals has appointed Narayan Saraf as the Chief Financial Officer of the Company with effect from 23 February 2024.Powered by Capital Market - Live News